Get Live Data

Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. STATEMENT RE COHERUS BIOSCIENCES, INC.

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.85
Bid: 0.84
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.01 (1.19%)
Open: 0.85
High: 0.00
Low: 0.00
Prev. Close: 0.85
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

STATEMENT RE COHERUS BIOSCIENCES, INC.

10 May 2024 15:11

RNS Number : 0397O
BioPharma Credit PLC
10 May 2024
 

BioPharma Credit PLC

10 May 2024

 

 

 

 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

STATEMENT RE Coherus BIOSCIENCES, Inc.

 

Pharmakon Advisors, LP, the investment manager of the Company, notes the announcement released 9 May 2024 by Coherus Biosciences, Inc. ("Coherus") regarding entering into a combined term loan and product royalty financing agreement with Barings (the "New Financing"). The New Financing allowed Coherus to fully pay off its remaining USD$75 million senior secured term loan, of which the Company had an investment of USD$37.5 million.

 

The Company had previously announced on 10 January 2022 an investment in a senior secured loan to Coherus of up to USD$150 million in up to three tranches. The Company had previously funded US$125 million, of which USD$87.5 million was repaid as referenced in the Company's announcement on 6 February 2024. The remaining USD$37.5 million was repaid to the Company in connection with the New Financing. In connection with this final repayment, the Company received US$39.8 million in total, including USD$2.3 million of accrued interest, and prepayment and make-whole fees.

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 509

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUBUAUPCGCU
12345678910
Date   Source Headline
24th Mar 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Mar 20237:10 amRNSAppointment of New Director
22nd Mar 20237:05 amRNSDividend Declaration
22nd Mar 20237:00 amRNSAnnual Financial Report
13th Mar 20237:00 amRNSSTATEMENT REGARDING SILICON VALLEY BANK
1st Mar 20237:00 amRNSNOTICE OF FULL YEAR RESULTS
21st Feb 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
1st Feb 20232:00 pmRNSTotal Voting Rights
23rd Jan 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
9th Jan 20236:15 pmRNSTransaction in Own Shares
3rd Jan 20235:28 pmRNSTotal Voting Rights
29th Dec 20226:15 pmRNSTransaction in Own Shares
21st Dec 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Dec 20226:15 pmRNSTransaction in Own Shares
16th Dec 20226:15 pmRNSTransaction in Own Shares
15th Dec 20226:15 pmRNSTransaction in Own Shares
14th Dec 20226:15 pmRNSTransaction in Own Shares
13th Dec 20226:15 pmRNSTransaction in Own Shares
12th Dec 20226:15 pmRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTotal Voting Rights
21st Nov 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Nov 20227:00 amRNSNEW INVESTMENT OF UP TO US$50.0 MILLION
15th Nov 20226:15 pmRNSTransaction in Own Shares
14th Nov 20226:15 pmRNSTransaction in Own Shares
11th Nov 20226:15 pmRNSTransaction in Own Shares
10th Nov 20226:15 pmRNSTransaction in Own Shares
9th Nov 20226:15 pmRNSTransaction in Own Shares
8th Nov 20226:15 pmRNSTransaction in Own Shares
7th Nov 20226:15 pmRNSTransaction in Own Shares
7th Nov 20227:00 amRNSUPDATES TO THE DISCOUNT CONTROL MECHANISM
4th Nov 20226:15 pmRNSTransaction in Own Shares
4th Nov 20223:26 pmRNSEdison issues review on BioPharma Credit (BPCR)
3rd Nov 20226:15 pmRNSTransaction in Own Shares
1st Nov 20224:37 pmRNSTotal Voting Rights
31st Oct 20226:15 pmRNSTransaction in Own Shares
28th Oct 20226:15 pmRNSTransaction in Own Shares
26th Oct 20226:15 pmRNSTransaction in Own Shares
25th Oct 20226:15 pmRNSTransaction in Own Shares
24th Oct 20226:15 pmRNSTransaction in Own Shares
24th Oct 20224:38 pmRNSDirector/PDMR Shareholding
24th Oct 20224:37 pmRNSDirector/PDMR Shareholding
21st Oct 20226:15 pmRNSTransaction in Own Shares
20th Oct 20226:15 pmRNSTransaction in Own Shares
20th Oct 20227:00 amRNSNew US$140.0 Million Investment
18th Oct 20226:15 pmRNSTransaction in Own Shares
17th Oct 20226:15 pmRNSTransaction in Own Shares
14th Oct 20226:15 pmRNSTransaction in Own Shares
14th Oct 20225:44 pmRNSHolding(s) in Company
13th Oct 20226:15 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSSPECIAL DIVIDEND DECLARATION AND NET ASSET VALUES
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.